Ian Dixon

Vision Systems Pty Ltd. develops, manufactures, and distributes technology products and services to the healthcare markets. It produces automated system solutions and vitro diagnostic instruments for cancer detection. The company was founded in 1984 and is headquartered in Mount Waverley, Australia.

Part of Cynata Therapeutics Ltd., Cynata, Inc. is a clinical-stage biotechnology company based in Blackburn, Australia. The company listed on the Australian Securities Exchange in November 2013, following a reverse takeover of Eco Quest Ltd. Cynata's Cymerus™ technology addresses the complexities and challenges of manufacturing stem cells at commercial scale, specifically targeting ARDS, an inflammatory process leading to respiratory failure. The technology is based on mesenchymoangioblasts (MCAs), which are versatile stem cells. The company was founded by Ian Dixon. Cynata was acquired by Cynata Therapeutics Ltd. on December 01, 2013.

Medigard Ltd. engages in the design and development of safety medical devices and associated products. It offers auto-retractable syringes, manual retractable syringes, blood collection device, intravenous valves and flash back needle. The company was founded in 1999 and is headquartered in Main Beach, Australia.

Exopharm Ltd. engages in the research and development of biopharmaceutical drugs. The company was founded by Ian Dixon and Gregor Lichtfuss in 2013 and is headquartered in Camberwell, Australia.